Back to search

Spain· ES:60602

FANHDI 100 UI FVIII/120 UI FVW POR ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE

A medicinal product containing factor con willebrand + factor viii, registered in Spain by Instituto Grifols S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedFANHDI 100 UI FVIII/120 UI FVW POR ml…ATC—REGISTER NO.ES:60602PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
factor con Willebrand + factor VIII
Manufacturer
Instituto Grifols S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Factor con willebrand + factor viii in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All factor con willebrand + factor viii products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb2e5a0d-97c8-44f7-a422-c6337fd6ec44
GET /v1/drugs/cb2e5a0d-97c8-44f7-a422-c6337fd6ec44?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":786236400000}",
  "nregistro": "60602",
  "substance": "factor con Willebrand + factor VIII"
}

See everything about factor con willebrand + factor viii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.